BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Histogenics Corporation 

830 Winter Street
3rd Floor
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-547-7900 Fax: 781-547-4452


SEARCH JOBS


Industry
Biotechnology

Segment
Research





 Company News
Histogenics Corporation Announces Appointment Of John H. Johnson To Its Board of Directors 11/14/2013 9:43:20 AM    More...
Histogenics Corporation Announces Nancy Lynch, M.D., as CMO 10/28/2013 6:39:51 AM    More...
Histogenics Corporation Announces Key Additions to Management Team 8/20/2013 6:55:06 AM    More...
Peter Greenleaf Appointed New CEO at Histogenics Corporation 6/10/2013 7:29:56 AM    More...
Histogenics Corporation Proudly Supports the Major League Soccer Medical Symposium to Raise Awareness on Sports-Related Injuries 1/10/2013 9:40:17 AM    More...
Kevin Rakin Appointed to the Histogenics Corporation Board of Directors 12/3/2012 10:47:12 AM    More...
Histogenics Corporation Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial 7/26/2012 10:18:21 AM    More...
Histogenics Corporation Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial 7/26/2012 9:18:14 AM    More...
Histogenics Corporation Brings In $49 Million for Tissue Regeneration - and Recapitalization 7/24/2012 7:22:51 AM    More...
Histogenics Corporation Announces Publication in Journal of Bone and Joint Surgery Demonstrating that NeoCart® is Associated With Greater Clinical Efficacy Two Years After Treatment than Current Standard of Care, Microfracture Surgery 6/6/2012 2:01:05 PM    More...
123

//-->